K J Roozendaal B de Valk J J A ten Velden H J van der Woude B B R Kroon
10.1038/sj.bjc.6601074
Br J Cancer
2003 Jul 21;89(2):243-5.
CC BY
https://pubmed.ncbi.nlm.nih.gov/12865909/
Antineoplastic Agents / pharmacology Interferon-alpha / pharmacology Sarcoma / drug therapy Soft Tissue Neoplasms / drug therapy
Antineoplastic Agents / pharmacology Interferon-alpha / pharmacology Sarcoma / drug therapy Soft Tissue Neoplasms / drug therapy Case Reports Adult Antineoplastic Agents / adverse effects Female Humans Interferon alpha-2 Interferon-alpha / adverse effects Psychotic Disorders / etiology Recombinant Proteins Sarcoma / pathology Soft Tissue Neoplasms / pathology Treatment Outcome Antineoplastic Agents Interferon alpha-2 Interferon-alpha Recombinant Proteins
PMC2394261
12865909
Alveolar soft-part sarcoma responding to interferon alpha-2b
2003